Epigral Limited shares surged over four percent on Wednesday, April 3. This rally was fueled by the successful commissioning of an additional 45,000 TPA (tonnes per annum) capacity for CPVC (Chlorinated Polyvinyl Chloride) resin at its Dahej facility in Gujarat. With this expansion, Epigral’s total CPVC resin capacity has reached 75,000 TPA, establishing it as the largest CPVC resin facility globally at a single location.
Alongside expanding its CPVC resin capacity, Epigral is diversifying into CPVC compound production with a projected capacity of 35,000 TPA. This project is currently underway and is expected to become operational by the first quarter of the financial year 2025.
As of 2:50 pm, Epigral’s shares were trading 3% higher at ₹1,362.90 on NSE.
CPVC resin and compound play crucial roles in producing CPVC pipes and fittings, known for their exceptional heat and chemical resistance, making them ideal for various domestic and industrial applications. The company stated that India’s demand for CPVC stands at around 250,000 tonnes per annum and continues to grow steadily, with an anticipated annual growth rate ranging between 10% and 13%.
